Retreatment with bendamustine is safe and effective against relapsed indolent lymphoid malignancies

Eri Matsuki

Presentation information

Oral Session

Oral Session 3-8C Bendamustine for indolent Lymphoma,

Sun. Oct 14, 2018 1:50 PM - 2:50 PM No.8 (Osaka International Convention Center, 10F 1002)

Chair: Masataka Okamoto (Fujita Health University School of Medicine Department of Hematology, Japan)

[OS3-8C-5] Retreatment with bendamustine is safe and effective against relapsed indolent lymphoid malignancies

Eri Matsuki, Takaaki Toyama, Koichi Murakami, Chieko Sumiya, Yusuke Yamane, Yuya Koda, Masatoshi Sakurai, Daiki Karigane, Keiichi Tozawa, Risa Hashida, Ryohei Abe, Kohei Shiroshita, Yuki Sato, Taku Kikuchi, Jun Kato, Takayuki Shimizu, Takehiko Mori, Shinichiro Okamoto (Department of Medicine, Keio University School of Medicine, Tokyo, Japan)

Abstract password authentication.
Password is written on a program and abstract book.